Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Israel Medical Association Journal : IMAJ
|
May 5, 2017
Women's Issues in Antiphospholipid Syndrome
Emmanouil Papadakis, Anastasia Banti, Anna Kioumi
Leukemia Research
|
July 6, 2006
Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis
Evangelos Terpos, Evgenia Verrou, Anastasia Banti, et al.
British Journal of Haematology
|
August 8, 2006
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients
Kostas Zervas, Evgenia Verrou, Zisis Teleioudis, et al.
Journal of Immunology Research
|
May 8, 2015
TACI expression and signaling in chronic lymphocytic leukemia
Antigoni Mamara, Anastasios E Germenis, Maria Kompoti, et al.
Diagnostics (Basel, Switzerland)
|
September 13, 2025
Rotational Thromboelastometry (ROTEM) Hemostasis Profile in Pregnant Women with Preeclampsia and Their Offspring: An Observational Study
Christos-Georgios Kontovazainitis, Dimitra Gialamprinou, Alexandra Fleva, et al.
Annals of Hematology
|
March 22, 2007
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma
Eirini Katodritou, Evangelos Terpos, Konstantinos Zervas, et al.
Leukemia Research
|
June 15, 2007
Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: first reported case
Eirini Katodritou, Charalambos Kartsios, Vassiliki Gastari, et al.
Hematological Oncology
|
August 6, 2024
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group
Evgenia Verrou, Sotirios G Papageorgiou, Maria Bouzani, et al.
Hematological Oncology
|
February 14, 2021
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas
Maria Dimou, Sotirios G Papageorgiou, Niki Stavroyianni, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Israel Medical Association Journal : IMAJ
|
May 5, 2017
Women's Issues in Antiphospholipid Syndrome
Emmanouil Papadakis, Anastasia Banti, Anna Kioumi
Leukemia Research
|
July 6, 2006
Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis
Evangelos Terpos, Evgenia Verrou, Anastasia Banti, et al.
British Journal of Haematology
|
August 8, 2006
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients
Kostas Zervas, Evgenia Verrou, Zisis Teleioudis, et al.
Journal of Immunology Research
|
May 8, 2015
TACI expression and signaling in chronic lymphocytic leukemia
Antigoni Mamara, Anastasios E Germenis, Maria Kompoti, et al.
Diagnostics (Basel, Switzerland)
|
September 13, 2025
Rotational Thromboelastometry (ROTEM) Hemostasis Profile in Pregnant Women with Preeclampsia and Their Offspring: An Observational Study
Christos-Georgios Kontovazainitis, Dimitra Gialamprinou, Alexandra Fleva, et al.
Annals of Hematology
|
March 22, 2007
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma
Eirini Katodritou, Evangelos Terpos, Konstantinos Zervas, et al.
Leukemia Research
|
June 15, 2007
Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: first reported case
Eirini Katodritou, Charalambos Kartsios, Vassiliki Gastari, et al.
Hematological Oncology
|
August 6, 2024
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group
Evgenia Verrou, Sotirios G Papageorgiou, Maria Bouzani, et al.
Hematological Oncology
|
February 14, 2021
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas
Maria Dimou, Sotirios G Papageorgiou, Niki Stavroyianni, et al.
Page
of 1